Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.
Press releases published on September 10, 2025
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will participate as a panelist in the …
AAFA Bill to Require Allergen Labeling in Restaurants Passes in California
Washington, DC, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement on news that the California Assembly and Senate passed SB 68 – the Allergen Disclosure for Dining Experiences (ADDE) Act. …
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform
RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims …
Partnership between Corewell Health and Nudj Health drives progress in chronic condition management
AUSTIN, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Corewell Health™ patients who used virtual lifestyle medicine services through a partnership with Nudj Health saw significant improvements in key mental and cardiometabolic health outcomes including a …
Johns Hopkins Health Plans Opens 2026 Grant Application Period
HANOVER, Md., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has launched the grant application period for its 2026 Corporate Giving Program. Local nonprofit organizations are encouraged to apply for funding to support programs that address …
Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology
Collaboration aims to create the lab of the future, enabling safer, faster, and more precise interventions Key Benefits of Partnership Integration of VR and imaging: Combines Realize Medical’s VR platform with Canon’s imaging solutions for an immersive …
Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors
LOS ANGELES, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that the final patient has enrolled in its …
Niederländische Plattform macht dermatologische Versorgung weltweit unmittelbar zugänglich
BERGEN OP ZOOM, Niederlande, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Es gibt eine neue niederländische Plattform, die dermatologische Versorgung auf internationaler Ebene zugänglich macht. Dermatology2Go (eine Initiative von Webcamconsult) wurde von zwei …
Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier
BERGEN OP ZOOM, Pays-Bas, 10 sept. 2025 (GLOBE NEWSWIRE) -- Une nouvelle plateforme néerlandaise a été lancée pour rendre les soins dermatologiques accessibles à l’international. Dermatology2Go (une initiative de Webcamconsult) a été développée par deux …
Plataforma holandesa torna o atendimento dermatológico instantaneamente acessível em todo o mundo
BERGEN OP ZOOM, Países Baixos, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Uma nova plataforma holandesa foi lançada, tornando o atendimento dermatológico acessível internacionalmente. Dermatology2Go (uma iniciativa da Webcamconsult) foi desenvolvida por dois …
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to start the IND-enabling program for the NN-840 program with an IND submission expected next year This NIH grant award strongly confirms the scientific and clinical promise of the innovative …
Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices
Arlington, Virginia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) has signed a memorandum of understanding with the Saudi Food and Drug Authority (SFDA), cementing a mutual commitment to enhance …
neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
Munich, Germany; Atlanta, Georgia - September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance, today announced it has received FDA clearance for the treatment of Major …
Eleos Launches Smarter Support for Group Therapy and SUD Care
New Groups capability represents the first AI solution to deliver individual speaker summaries for group therapy sessions, enabling SUD organizations to achieve documentation compliance at scale Eleos to unveil product updates at Quarterly Launch Event on …
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
CALABASAS, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today …
Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades
SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Wellcome Leap, a U.S. non-profit, and Pivotal, a group of organizations founded by Melinda French Gates, today announced a $100 million partnership to accelerate women’s health research. The joint effort will …
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …